| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
|
28 |
29 |
30 |
31 |
1 |
2 |
3 |
|
|
|
|
|
|
|
|
|
4 |
5 |
6 |
8 |
9 |
10 |
|
|
|
|
|
|
|
|
|
|
11 |
12 |
16 |
17 |
|||
|
|
|
|
|
|||
|
22 |
23 |
24 |
||||
|
|
|
|
||||
|
27 |
28 |
29 |
30 |
1 |
||
|
|
|
|
|
|
Dr. Peter Hollmann, Chief Medical Officer at Brown Medicine, serves as our current CTC-RI Board President. Dr. Hollmann weighs-in on the work of CTC-RI in 2021.
As board president, what was the biggest success of 2021 for CTC-RI?
Through this pandemic, resources and efforts to support providers have been more important than ever. Matthew Malek, MD, MPH, Medical Director of Provider Experience at Thundermist Health Center will be featured on our December 10 Breakfast of Champions panel, "Addressing Clinician and Clinical Team Well-being During the Pandemic."
At December’s Practice Reporting / Transformation meeting, Bernadette Parrillo, QI Specialist at RIPCPC, provided an overview of NCQA’s Annual Reporting changes to expect in 2022.
During the December Board of Directors meeting, Nelly Burdette, Psy.D, CTC-RI IBH Senior Director presented a 2-year IBH project review.
The first part of the November Clinical Strategy Committee (CSC) meeting was a discussion of CTC-RI Board of Directors strategic planning and 2022-23 CSC priorities led by Jim Berson, Fio Partners and Pano Yeracaris MD MPH, CTC-RI Chief Clinical Strategist.
We hope that you can join us at tomorrow’s Breakfast of Champions meeting for a panel discussion focusing on addressing clinician and clinical team well-being during COVID-19. The meeting will feature the following panelists:
The mission of CTC-RI is to support the continuing transformation of primary care in Rhode Island as the foundation of an ever-improving integrated, accessible, affordable, and equitable health care system. CTC-RI brings together critical stakeholders to implement, evaluate and spread effective multi-payer models to deliver, pay for and sustain high-quality, comprehensive, accountable primary care.